Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
ROCURONIUM BROMIDE MEDICIANZ; ROCURONIUM BROMIDE MEDSURGE (Medicianz Healthcare Pty Ltd)
Product name
ROCURONIUM BROMIDE MEDICIANZ; ROCURONIUM BROMIDE MEDSURGE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
138 (255 working days)
Active ingredients
rocuronium bromide
Registration type
New generic medicine
Indication
ROCURONIUM BROMIDE MEDICIANZ; ROCURONIUM BROMIDE MEDSURGE (solution for injection) is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, and paediatric patients from term newborn infants to adolescents.
In adults, rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated.
In adults, rocuronium is also indicated as an adjunct in the intensive care unit (ICU) to facilitate mechanical ventilation.